Search
Breast Cancer Risk Calculator Can Assess Risk of Advanced Breast Cancer
Upcoming Conference to Focus on Breast Density and Prediction of Advanced and Interval Breast Cancer RiskUCSF and I-SPY 2 Breast Cancer Researchers Develop Newly Redefined Breast Cancer Response Subtypes
Research scientists and statisticians from UC San Francisco have developed improved biomarker classifications as part of their research results in the I-SPY 2 trial for high-risk breast cancer patients.Don’t Miss a Beat on A-fib: How to Make the Right Plans for Individual Patients
This practical, data-fueled talk from Edward P. Gerstenfeld, MD, MS, FACC, chief of the UCSF Cardiac Electrophysiology and Arrhythmia Service, will help PCPs better understand how to assess stroke risk; make treatment decisions...Primary Care of the IBD Patient: Risk Factors, Symptoms and the Value of Timely Therapeutics
In this update on inflammatory bowel disease, gastroenterologist Kendall Beck, MD, notes contributing causes, explains which tests have value, gives keys to distinguishing ulcerative colitis and Crohn’s...Keeping the Eye in Sight: Ensure Proper Primary Care for Ocular Injuries
When presented with common eye issues – from corneal abrasions and foreign bodies to potentially fractured orbital bones – providers need to make prompt diagnoses, assess urgency and take steps to limit damage.A Guide to Gout: Keys to Recognizing and Managing This Damaging Disease
Noting that gout is common yet under-recognized and undertreated, rheumatologist Kerstin Morehead, MD, presents a valuable update on risk factors, associated conditions, and treatments for both acute flares and chronic disease.Drug Turns Cancer Gene Into "Eat Me" Flag for Immune System
UCSF-led study shows promising pre-clinical results in killing cancer cells resistant to current KRAS-targeted treatments.Drug Targeting Tauopathies in Mice Reveals Sex Differences in Response
Microglia are cells that are central to both brain health as well as disease progression in many neurological conditions.“CAR Pooling” Screens Identify Most Effective Cancer Immunotherapy Cells
New approach by UCSF researchers analyzes how well different re-engineered T cells work against cancer.How AI Found the Words to Kill Cancer Cells
Predictive model allows researchers to encode commands for cells to carry out.UCSF Laser Interstitial Thermal Therapy
UCSF Laser Interstitial Thermal TherapyEnhancing Care for Thoracic Oncology Surgery Patients
Building on a decades-long reputation for innovation in thoracic surgery, UC San Francisco’s Thoracic Surgery and Oncology Clinic has improved the overall experience for patients undergoing lung and esophageal cancer treatment while continuing to maintain strong outcomes.UCSF Lung Transplant Clinic in Roseville
UCSF Lung Transplant Clinic in RosevilleNavigating the Maze of Breast Cancer Guidelines: Efficient Paths to Personalized Screening
To help PCPs address patients’ breast cancer screening concerns, surgeon Shoko Emily Abe, MD, FACS, breaks down the multitude of screening directives and modalities, with a focus on the needs of those at average risk and those with dense breast tissue.Aggressive Surgery Increases Survival with Low-Grade Brain Tumors
UCSF-Led study shows extensive resection results in longer survival for glioma patientsRace-Based Equations May Lead to Under-Treatment of Lung Disease in Black Patients
Using race-based equations to evaluate lung disease -- a practice promoted in the 2019 guidelines of the American Thoracic Society -- may mean that severe lung disease in Black patients is classified as moderate disease, according to a UCSF-led study.Cerebral Cavernous Malformation Treatments Relieve Disparate Symptoms
Two patients with severe yet different neurological symptoms were referred to UCSF for emergent neurosurgical evaluation. Both were found to have previously undiagnosed cerebral cavernous malformations (CCMs), but each patient’s treatment was unique.First “Neuroprosthesis” Expands Vocabulary and Mobility for Man With Paralysis in New Milestone
The first “neuroprosthesis,” developed by UCSF researchers in 2021, translates brain signals from a man with severe paralysis directly into words that appear as text on a screen. Using this brain-machine interface, he can also move a robotic arm to manipulate objects.Novel Metabolic Imaging Method Detects Prostate Cancer Aggressiveness
UCSF investigators have shown that adding an emerging metabolic imaging technique to MR–transrectal ultrasound fusion prostate biopsies makes it possible to detect the extent and aggressiveness of prostate cancer more accurately than ever.Cardiology Transfer Guide
Cardiology Transfer GuideUCSF Health Transfer Center Intake Workflow
UCSF Health Transfer Center Intake WorkflowUCSF Research Instrumental in Approval of Breakthrough Diabetes Therapy
The US Food and Drug Administration (FDA) recently approved the use of a new drug Teplizumab, an immunotherapy drug which has been shown to significantly delay the onset of type 1 diabetes.Alan P. Venook, MD, Recognized With Luminary Award for Gastrointestinal Cancers
Alan P. Venook, MD, a renowned expert in colorectal and liver cancers, has been announced as one of the winners of the 2022 Luminary Awards in Gastrointestinal (GI) Cancers.International Hematologic Conference Features UCSF Health Experts
Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 64th Annual Meeting and Exposition.